Rufloxacin

DB13772InvestigationalSmall molecule

Rufloxacin is a fluoroquinolone antibiotic indicated in the treatment of susceptible respiratory infections and uncomplicated cystitis. An antibiotic used to treat certain lung and bladder infections.

Chemical structure of Rufloxacin
Mechanism
Curator reviewed · 1 reference
Formula / weight
C17H18FN3O3S · 363.407 g/mol (avg)

Resolves to

Compound
UNIIY521XM2900CAS101363-10-4ChEMBLCHEMBL295619ChEBI8909KEGGD02474
Clinical / RWD
ATCJ01MA10
Structure
InChIKeyNJCJBUHJQLFDSW-UHFFFAOYSA-NSMILESCN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN3CCSC1=C23)C(O)=O
Targets
P43700gyrA

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
870Drug interactionsStructured to mechanism, not free text
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
7ContraindicationsEach with its own population and attribute set
Sign in
18Marketed productsAcross 1 country and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Rufloxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In